Treatment of BPH With CO2 Serenoa +PEA as Monotherapy or in Combination With Tamsulosin: ProSeRePEA Trial

Conditions: Benign Prostatic Hyperplasia; Urinary Obstruction; Lower Urinary Tract Symptoms Interventions: Drug: PEAPROSTIL 600 + Tamsulosin 0.4 mg; Drug: Tamsulosin 0.4 mg; Drug: PEAPROSTIL 600 mg Sponsors: Azienda Ospedaliero Universitaria Maggiore della Carita Recruiting

https://clinicaltrials.gov/study/NCT06181175

Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials

More News: Benign Prostatic Hyperplasia | Research